Sunrun Inc.

First Solar, Inc.

Enphase Energy, Inc.

Freedom Broker recommends selling residential solar panel stocks, which could be hit hard by potential tax changes forthcoming in the U.S. The "Big Beautiful Bill" entails scrapping a 30% tax credit for households that install solar panels within six months of the bill's passage, as well as power production and investment credits for wind and solar companies six years earlier than the program was supposed to end.&nbsp;

Freedom Broker names clean energy winners and losers from proposed U.S. tax changes

Galectin Therapeutics Inc.

After U.S. strikes over the weekend, the market is now in wait-and-see mode. Meanwhile, a biotech got a boost from an initiation of coverage last week that made it the biggest gainer, while a solar power stock retreated the most amid negative regulatory developments. This is what happened in small caps last week and what to expect in the week ahead.

Small cap weekly update: Fallout from U.S. strike on Iran could elevate volatility

Eutelsat Communications S.A.

Eutelsat needs to find another EUR2.65 billion to operate sustainably, Fitch estimates

Starlink rival Eutelsat sees stock soar 30% as France to invest EUR1.35 bln


The Western Union Company

Freedom Broker has issued a trade idea to buy Western Union, the global financial services and communication company that specializes in money transfers and payment solutions, which has a capitalization of $2.8 billion. The stock offers an outstanding dividend yield and upside of 15% over a two-month horizon.

Freedom Broker issues trade idea to buy Western Union, highlighting dividend yield

Perfect Corp.

How the Taiwanese startup landed Chanel and Google as clients and what challenges it now faces from Trump's tariffs


Perfect Corp. strategy chief tells Oninvest about the firm's past, present and future

SS Innovations International, Inc.

SS Innovations, a developer of surgical robotic technologies, soared 42% yesterday, June 18. That is how investors reacted to the news of the successful completion of its first robotic cardiac surgery in the Western Hemisphere. The stock has been trading on the Nasdaq for only about two months.

Surgical robot maker SS Innovations soars after first cardiac surgery in Americas

John Wiley & Sons, Inc.

Quotes of John Wiley &amp; Sons, commonly known as Wiley, a small-cap publishing company that focuses on academic publishing and instructional materials, <a href="https://www.marketwatch.com/investing/stock/wly">soared</a>&nbsp;10% yesterday, June 17. The driver was the company's&nbsp;<a href="https://s27.q4cdn.com/812717746/files/doc_financials/2025/q4/Q425-Earnings-Presentation.pdf">financial results</a>&nbsp;for the fiscal-2025 fourth quarter and full year, which beat&nbsp;Wall Street forecasts. The company fingered its leveraging of AI as one of the reasons for the performance.

Earnings of small publisher Wiley beat expectations amid AI push

Sarepta Therapeutics, Inc.

Quotes of Sarepta Therapeutics, a small-cap developer of precision genetic medicines to treat rare neuromuscular and central nervous system diseases, plummeted 42% yesterday, June 16, to hit a nine-year low. The company reported the death of the second teenager in three months who was taking its drug to treat muscular dystrophy. In addition, Sarepta has withdrawn its revenue guidance for 2025 as it may be forced to pull the drug from the market, analysts warn.

Sarepta tanks after death of second teen taking its gene therapy; outlook 'cloudy'

AIRO Group Holdings, Inc.

Airo Group Holdings, a small-cap drone maker, has&nbsp;<a href="https://www.marketwatch.com/story/heres-why-drone-maker-airos-stock-is-still-hot-despite-weak-demand-for-the-ipo-e6a268f0?mod=home_lead">soared</a> to nearly three times its IPO price in the first two days of trading, though shares were offered at well below the expected price. Airo is set to benefit as demand for military drones grows worldwide, analysts say.&nbsp;&nbsp;

After weak IPO, drone maker Airo soars amid Israel-Iran conflict, rising drone demand

Regencell Bioscience Holdings Limited

Tesla, Inc.

Apple Inc.

Since the beginning of the year, Regencell Bioscience Holdings, a Hong Kong-based and Nasdaq-listed company that develops traditional Chinese medicine, <a href="https://finance.yahoo.com/quote/RGC/">has soared</a>&nbsp;more than 46,000%, <a href="https://www.bloomberg.com/news/articles/2025-06-16/herbal-medicine-stock-with-no-sales-sees-wild-rally-top-64-000?sref=Y0jVLcFo&amp;embedded-checkout=true">Bloomberg</a>&nbsp;wrote yesterday.&nbsp;Just a year ago, the company was worth about $53 million, while now its market capitalization is approaching $30 billion, even though it has never turned a profit and has zero revenue.&nbsp;

Herbal medicine maker Regencell Bioscience skyrockets 46,000% this year on no news

Cellebrite DI Ltd.

Telos Corporation

Nuix Limited

Micro Systemation AB

In 2025, digital forensics and cybersecurity technologies are increasingly in the spotlight due to rising numbers of cyberattacks and growing regulatory requirements. The U.S. SEC&nbsp;<a href="https://auditboard.com/blog/sec-cybersecurity-rules">requires</a> public companies to report major cyber incidents within four business days, and a&nbsp;<a href="https://www.cyberseek.org/docs/06-02-2025_CyberSeek_June_2025.pdf">shortage</a> of specialists is spurring demand for automated solutions. As a result, the global digital forensics market is growing rapidly, with&nbsp;<a href="https://www.marketsandmarkets.com/PressReleases/digital-forensics.asp">expected</a>&nbsp;growth from $13 billion in 2025 to over $22 billion by 2030.&nbsp;

Six small caps punching above their weight in the cybersecurity market

Cal-Maine Foods, Inc.

Brinker International, Inc.

Commvault Systems, Inc.

Evercore ISI&nbsp;<a href="https://www.marketwatch.com/articles/small-cap-stocks-buy-cal-maine-485a34ff?mod=newsviewer_click_seemore">has recommended</a>&nbsp;six stocks to help investors to play the small-cap rally better than a simple bet on the Russell 2000 index. The investment bank screened for small caps that are in the highest quintile of profitability based on net profit margins and return on equity, as well as those in the top quintile of sentiment based on the change in analysts’ revenue and earnings estimates in the past three months. In addition, all of the Evercore ISI picks are able to raise prices to offset tariff-related costs and protect their profit margins.

Small caps